Literature DB >> 25133039

Diagnosis and treatment of gastroesophageal reflux disease.

Raul Badillo1, Dawn Francis1.   

Abstract

Gastroesophageal reflux disease (GERD) is a common disease with a prevalence as high as 10%-20% in the western world. The disease can manifest in various symptoms which can be grouped into typical, atypical and extra-esophageal symptoms. Those with the highest specificity for GERD are acid regurgitation and heartburn. In the absence of alarm symptoms, these symptoms can allow one to make a presumptive diagnosis and initiate empiric therapy. In certain situations, further diagnostic testing is needed to confirm the diagnosis as well as to assess for complications or alternate causes for the symptoms. GERD complications include erosive esophagitis, peptic stricture, Barrett's esophagus, esophageal adenocarcinoma and pulmonary disease. Management of GERD may involve lifestyle modification, medical therapy and surgical therapy. Lifestyle modifications including weight loss and/or head of bed elevation have been shown to improve esophageal pH and/or GERD symptoms. Medical therapy involves acid suppression which can be achieved with antacids, histamine-receptor antagonists or proton-pump inhibitors. Whereas most patients can be effectively managed with medical therapy, others may go on to require anti-reflux surgery after undergoing a proper pre-operative evaluation. The purpose of this review is to discuss the current approach to the diagnosis and treatment of gastroesophageal reflux disease.

Entities:  

Keywords:  Acid suppression; Esophageal disease; Fundoplication; Gastroesophageal reflux disease; Upper gastrointestinal tract disorder

Year:  2014        PMID: 25133039      PMCID: PMC4133436          DOI: 10.4292/wjgpt.v5.i3.105

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  48 in total

1.  The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial.

Authors:  W C Orr; S Goodrich; S Wright; K Shepherd; M Mellow
Journal:  Neurogastroenterol Motil       Date:  2012-03-08       Impact factor: 3.598

2.  Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?

Authors:  L Tefera; M Fein; M P Ritter; C G Bremner; P F Crookes; J H Peters; J A Hagen; T R DeMeester
Journal:  Am Surg       Date:  1997-10       Impact factor: 0.688

3.  The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.

Authors:  Hashem B El-Serag; Stephanie Fitzgerald; Peter Richardson
Journal:  Am J Gastroenterol       Date:  2009-06-30       Impact factor: 10.864

4.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

Review 5.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

6.  Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.

Authors:  D A Katzka; V Paoletti; L Leite; D O Castell
Journal:  Am J Gastroenterol       Date:  1996-10       Impact factor: 10.864

7.  LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.

Authors:  Luigi Bonavina; Greta Saino; John C Lipham; Tom R Demeester
Journal:  Therap Adv Gastroenterol       Date:  2013-07       Impact factor: 4.409

8.  Complications and antireflux medication use after antireflux surgery.

Authors:  Jason A Dominitz; Christopher A Dire; Kevin G Billingsley; Jeffrey A Todd-Stenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

9.  A comparison of five maintenance therapies for reflux esophagitis.

Authors:  S Vigneri; R Termini; G Leandro; S Badalamenti; M Pantalena; V Savarino; F Di Mario; G Battaglia; G S Mela; A Pilotto
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245

10.  Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.

Authors:  Bart P L Witteman; Rob Strijkers; Eva de Vries; Liza Toemen; José M Conchillo; Wim Hameeteman; Pieter C Dagnelie; Ger H Koek; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

View more
  43 in total

1.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 2.  Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.

Authors:  John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2017-05-18       Impact factor: 22.682

3.  Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison.

Authors:  Su-Yeon Yu; Boram Lee; Treasure M McGuire; Hye-Jae Lee; Samantha A Hollingworth
Journal:  Eur J Clin Pharmacol       Date:  2019-12-10       Impact factor: 2.953

4.  LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.

Authors:  Tara T Doucet-O'Hare; Nemanja Rodić; Reema Sharma; Isha Darbari; Gabriela Abril; Jungbin A Choi; Ji Young Ahn; Yulan Cheng; Robert A Anders; Kathleen H Burns; Stephen J Meltzer; Haig H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 5.  Gastroesophageal reflux and congenital gastrointestinal malformations.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Eloisa Gitto; Carmelo Salpietro; Antonio Centorrino; Gianfranco Scalfari; Giuseppe Santoro; Pietro Impellizzeri; Carmelo Romeo
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

6.  Evaluations of life style factors and the severity of Gastroesophageal reflux disease; a case-control study.

Authors:  Saba Fakhrieh Asl; Fariborz Mansour-Ghanaei; Hooman Samadi; Farahnaz Joukar
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

7.  Relationship Between Meal Frequency and Gastroesophageal Reflux Disease (GERD) in Iranian Adults.

Authors:  Mehrbod Vakhshoori; Ammar Hassanzadeh Keshteli; Parvane Saneei; Ahmad Esmaillzadeh; Peyman Adibi
Journal:  Dig Dis Sci       Date:  2018-07-16       Impact factor: 3.199

Review 8.  The management of gastro-oesophageal reflux disease.

Authors:  Charlotte Keung; Geoffrey Hebbard
Journal:  Aust Prescr       Date:  2016-02-01

9.  Antireflux surgery leads to durable improvement in laryngopharyngeal reflux symptoms.

Authors:  Lindsay K Hessler; Yiwei Xu; Amber L Shada; Morgan K Johnson; Luke M Funk; Jacob A Greenberg; Anne O Lidor
Journal:  Surg Endosc       Date:  2021-02-02       Impact factor: 4.584

Review 10.  Concomitant Use of Levothyroxine and Proton Pump Inhibitors in Patients with Primary Hypothyroidism: a Systematic Review.

Authors:  Yuli Guzman-Prado; Roberto Vita; Ondrej Samson
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 6.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.